11:26AM ET 5/26/2022 MT NewswiresStoke Therapeutics (STOK) has an average buy rating among analysts, with a price target range of $38 to $70. (MT Newswires covers equity, commodity and...
3:24AM ET 5/23/2022 MT NewswiresStoke Therapeutics (STOK) on Friday filed a shelf registration statement for the potential sale of up to $400 million of its securities from time to time. ...
10:41AM ET 5/11/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
2:51PM ET 5/10/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...